WO2002038136A3 - Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle - Google Patents

Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle Download PDF

Info

Publication number
WO2002038136A3
WO2002038136A3 PCT/EP2001/012604 EP0112604W WO0238136A3 WO 2002038136 A3 WO2002038136 A3 WO 2002038136A3 EP 0112604 W EP0112604 W EP 0112604W WO 0238136 A3 WO0238136 A3 WO 0238136A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
transdermal administration
etheric oils
oils
skin friendly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/012604
Other languages
English (en)
French (fr)
Other versions
WO2002038136A2 (de
Inventor
Karl-Heinz Woeller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Priority to AT01993463T priority Critical patent/ATE287706T1/de
Priority to DE50105219T priority patent/DE50105219D1/de
Priority to AU2002216987A priority patent/AU2002216987A1/en
Priority to EP01993463A priority patent/EP1335714B1/de
Publication of WO2002038136A2 publication Critical patent/WO2002038136A2/de
Publication of WO2002038136A3 publication Critical patent/WO2002038136A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Wirkstoffhaltiges Matrixpflaster zur kontrollierten Abgabe von ätherischen Ölen die einer wirkstoffhaltigen, wasserunlöslichen haftklebrigen Matrix,wobei die haftklebrige Matrixfrei von Mineralölen und Klebharzen ist und aufgebaut ist aus: a) synthetischen Geüstpolymeren auf der Basis von Polyisobutylen u 25 bis 90 Gew.-%; b) amorphem Poly-α-olefin zu 5 bis 30 Gew.-%; c) aus einem unlöslichen, bevorzugt hydrophilen Füllstoff zu 0 bis 60 Gew.-% und d) ätherischen Ölen zu 0,5 bis 25 Gew.-%.
PCT/EP2001/012604 2000-11-11 2001-10-31 Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle Ceased WO2002038136A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT01993463T ATE287706T1 (de) 2000-11-11 2001-10-31 Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle
DE50105219T DE50105219D1 (de) 2000-11-11 2001-10-31 Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle
AU2002216987A AU2002216987A1 (en) 2000-11-11 2001-10-31 Skin friendly active ingredient plaster for especially transdermal administration of etheric oils
EP01993463A EP1335714B1 (de) 2000-11-11 2001-10-31 Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056011.3 2000-11-11
DE10056011A DE10056011A1 (de) 2000-11-11 2000-11-11 Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle

Publications (2)

Publication Number Publication Date
WO2002038136A2 WO2002038136A2 (de) 2002-05-16
WO2002038136A3 true WO2002038136A3 (de) 2002-11-21

Family

ID=7662997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/012604 Ceased WO2002038136A2 (de) 2000-11-11 2001-10-31 Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle

Country Status (6)

Country Link
EP (1) EP1335714B1 (de)
AT (1) ATE287706T1 (de)
AU (1) AU2002216987A1 (de)
DE (2) DE10056011A1 (de)
ES (1) ES2234927T3 (de)
WO (1) WO2002038136A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2666077C (en) * 2006-10-17 2016-06-28 Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh Adhesive label with bittering agent and fluidifying agents for natural airway secretions
EP2921184A1 (de) 2014-03-19 2015-09-23 LTS LOHMANN Therapie-Systeme AG Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341202A1 (de) * 1988-04-22 1989-11-08 Ciba-Geigy Ag Transdermale Monolithsysteme
EP0788792A1 (de) * 1994-11-29 1997-08-13 Hisamitsu Pharmaceutical Co., Inc. Pflaster des matrixtyps
WO2000045797A1 (en) * 1999-02-02 2000-08-10 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
DE19712359A1 (de) * 1997-03-25 1998-10-01 Labtec Gmbh System zur Arzneistoffinhalation
IT1305303B1 (it) * 1999-03-10 2001-05-04 Farmigea Spa Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.
DE10056010A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Pflaster mit hautpflegenden Substanzen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341202A1 (de) * 1988-04-22 1989-11-08 Ciba-Geigy Ag Transdermale Monolithsysteme
EP0788792A1 (de) * 1994-11-29 1997-08-13 Hisamitsu Pharmaceutical Co., Inc. Pflaster des matrixtyps
WO2000045797A1 (en) * 1999-02-02 2000-08-10 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Also Published As

Publication number Publication date
EP1335714A2 (de) 2003-08-20
EP1335714B1 (de) 2005-01-26
ES2234927T3 (es) 2005-07-01
AU2002216987A1 (en) 2002-05-21
ATE287706T1 (de) 2005-02-15
WO2002038136A2 (de) 2002-05-16
DE10056011A1 (de) 2002-05-16
DE50105219D1 (de) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2002038196A3 (de) Pflaster mit hautpflegenden substanzen
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
CA2276445A1 (en) Transdermal hormone-delivering therapeutic system
CA2274358A1 (en) Hydrophilic adhesive masses
CA2030178A1 (en) Transdermal therapeutic system comprising as active component buprenorphine
CA2308513A1 (en) Method and composition for delivering zinc to the nasal membrane
MXPA02005006A (es) Banda adhesiva.
CA2447302A1 (en) Two-phase, water-absorbent bioadhesive composition
GB2341550A (en) Gastroretentive controlled release microspheres for improved drug delivery
ITMI911486A1 (it) Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
CA2209711A1 (en) Plaster containing estradiol
WO2001030408A3 (en) Adhesive composition over a bioactive polymerization initiator
CA2333869A1 (en) Mousse composition
EP0297828A1 (de) Mit Medikamenten versehene Verbände
WO1994008571A3 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
CA2319903A1 (en) Medicated device for warts, corns, calluses and nails
CA2338859A1 (en) Estradiol-containing patch for transdermal administration of hormones
GB9825971D0 (en) Medicaments
ATE369124T1 (de) Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung nichtsteroidaler antirheumatika
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
EP0968712A4 (de) Felbinac enthaltendes Pflaster
WO2002038137A3 (de) Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung hyperämisierender wirkstoffe
WO2002038136A3 (de) Hautfreundliches wirkstoffpflaster zur transdermalen verabreichung ätherischer öle
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
WO2002022109A3 (en) Patch comprising diclofenac

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001993463

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002216987

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001993463

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001993463

Country of ref document: EP